A. Francis

The Non Mineral Axis Klotho-Vitamin D in Diabetic Nephropathy: Review

F. Nakhoul, Inbal Dahan, Hao Zhang, 2015 .

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

L. Kupčinskas, D. Ben Bashat, A. Sanyal, 2021, Nature Medicine.

Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients

A. Levy, F. Nakhoul, S. Basu, 2015, Journal of diabetes research.

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis

P. Fishman, N. Lev-Cohain, Inbal Itzhak, 2021, Alimentary pharmacology & therapeutics.

Diclofenac-lnduced coronary spasm in the absence of anaphylaxis or allergic manifestation.

W. Nseir, M. Mahamid, Wissam Khalaila, 2013, The Israel Medical Association journal : IMAJ.

Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply

P. Fishman, N. Lev-Cohain, Inbal Itzhak, 2022, Alimentary Pharmacology and Therapeutics.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.